155 related articles for article (PubMed ID: 22325225)
1. [Expression of EGFR, survivn and hnRNPA2/B1 in bronchial brushing cytology specimens and their significance in diagnosis of lung cancer].
Lu SS; Pan QJ; Zhao LL; Guo HQ; Zhang ZH; Cao J
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):621-5. PubMed ID: 22325225
[TBL] [Abstract][Full Text] [Related]
2. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens.
Liu YZ; Jiang YY; Wang BS; Hao JJ; Shang L; Zhang TT; Cao J; Xu X; Zhan QM; Wang MR
Cancer Cytopathol; 2014 Nov; 122(11):833-41. PubMed ID: 25045014
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.
Katsimpoula S; Patrinou-Georgoula M; Makrilia N; Dimakou K; Guialis A; Orfanidou D; Syrigos KN
Anticancer Res; 2009 Apr; 29(4):1373-82. PubMed ID: 19414390
[TBL] [Abstract][Full Text] [Related]
4. hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers.
Xuan Y; Wang J; Ban L; Lu JJ; Yi C; Li Z; Yu W; Li M; Xu T; Yang W; Tang Z; Tang R; Xiao X; Meng S; Chen Y; Liu Q; Huang W; Guo W; Cui X; Deng W
Mol Oncol; 2016 Apr; 10(4):610-24. PubMed ID: 26774881
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of a disintegrin and metalloprotease 8 (ADAM8) and epidermal growth factor receptor (EGFR) in non-small cell lung cancer].
Wu GC; Hu HC; Shi MH
Ai Zheng; 2008 Aug; 27(8):874-8. PubMed ID: 18710625
[TBL] [Abstract][Full Text] [Related]
7. Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.
Zhang X; Dang Y; Li P; Rong M; Chen G
Int J Clin Exp Pathol; 2014; 7(11):8096-104. PubMed ID: 25550857
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
[TBL] [Abstract][Full Text] [Related]
9. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
10. The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer.
Yu KL; Tsai TH; Ho CC; Liao WY; Lin CK; Hsu CL; Shih JY
Sci Rep; 2018 Apr; 8(1):5837. PubMed ID: 29643378
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
12. Protein expression and significance of VEGF, EGFR and MMP-9 in non-small cell lung carcinomas.
Jin Y; Li JP; Tang LY; Chen JN; Feng ZY; Liu Y; Zhou J; Shao CK
Asian Pac J Cancer Prev; 2011; 12(6):1473-6. PubMed ID: 22126484
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
14. Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: Validity and reliability with cutoff value.
Abe H; Takase Y; Sadashima E; Fukumitsu C; Murata K; Ito T; Kawahara A; Naito Y; Akiba J
Cancer Cytopathol; 2019 Sep; 127(9):598-605. PubMed ID: 31436913
[TBL] [Abstract][Full Text] [Related]
15. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection.
Fielding P; Turnbull L; Prime W; Walshaw M; Field JK
Clin Cancer Res; 1999 Dec; 5(12):4048-52. PubMed ID: 10632338
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
19. [Application of protein markers in combination with ThinPrep bronchial brush cytology in classification of lung cancer subtypes].
Yang Y; Pan QJ; Teng MF; Li ZL; Zhao LL; Han NJ; Gao YN; Cao J
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):616-9. PubMed ID: 19102942
[TBL] [Abstract][Full Text] [Related]
20. [Subcellular localization of survivin in non-small cell lung cancer].
He L; Hou M; Zhang J; Xu N; Chen P
Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
